Search results for abx831018

Motavizumab, Abbexa, abx831018

Motavizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Respiratory Syncytial Virus (RSV), for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Motavizumab is a second generation, ultra-potent, affinity-matured, humanized mAb derived from palivizumab that reduces replication of Respiratory Syncytial Virus (RSV), a pathogen which causes lower respiratory tract disease.